#WARNING:no index is registered index "YP_009724390.1" in "https://rest.uniprot.org/uniprotkb/" url "https://rest.uniprot.org/uniprotkb/YP_009724390.1.txt".
Please visit the UniProt website(https://www.uniprot.org), and get a proper ID/AC for your query protein.

Contact Molecules for Homologous Proteins

[Full Bars]
[SiteTable]


Summary Bars[0.0 %]


[Back to Search Page]
[Back to HOMCOS]

[SupCon3D]
[help] 		seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100]
[show] [download] [help]
PID QueryLength Homolgous Sequence in PDB UniProt Query TITLE
4094137 1273 500 YP_009724390.1()
QUERYSEQ 
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNK
SWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYN
YLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECS
NLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLM
SFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT
[BLAST file for PDB] (plain) (bar) (multiple alignment) [BLAST for UniProt: (plain) (bar) (multiple alignment) (PSSM file) ]

UniProt Feature Tables [YP_009724390.1()]

1273
region name description
1-1273 DISORDER predicted by DISOPRED

MONOMER
1273
pdb_id a1 identity[%]2 description
7tpr A 99.2 SPIKE_SARS2 Spike glycoprotein 
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue.
HETERO
1273 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
7fg2[1] B K-874A VHH[116 aa] A 100.0
/100.0		 12
/12		 SPIKE_SARS2 Spike glycoprotein
7upw[6] D SP1-77 Fab heavy chain[225 aa] A 100.0
/99.9		 13
/13		 SPIKE_SARS2 Spike glycoprotein
7mxp[3] F LP5 Fab Heavy Chain[119 aa] A 100.0
/99.9		 15
/15		 SPIKE_SARS2 Spike glycoprotein
7mxp[3] G LP5 Fab Light Chain[107 aa] A 100.0
/99.9		 11
/11		 SPIKE_SARS2 Spike glycoprotein
8gjm[1] D Heavy chain of 17B10 fab[119 aa] A 100.0
/99.9		 8
/8		 SPIKE_SARS2 Spike glycoprotein
8gjm[1] E Light chain of 17B10 fab[106 aa] A 100.0
/99.9		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7l2e[3] D 4-18 heavy chain[122 aa] A 100.0
/99.8		 18
/18		 SPIKE_SARS2 Spike glycoprotein
7l2e[3] E 4-18 light chain[109 aa] A 100.0
/99.8		 8
/8		 SPIKE_SARS2 Spike glycoprotein
8cyb[1] D pan-sarbecovirus nanobody 1-8[126 aa] A 100.0
/99.8		 21
/21		 SPIKE_SARS2 Spike glycoprotein
7l2d[1] B 1-87 heavy chain[127 aa] A 100.0
/99.8		 16
/16		 SPIKE_SARS2 Spike glycoprotein
7l2d[1] C 1-87 light chain[109 aa] A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cxn[3] D pan-sarbecovirus nanobody 2-57[126 aa] A 100.0
/99.8		 16
/16		 SPIKE_SARS2 Spike glycoprotein
8cxn[1] F pan-sarbecovirus nanobody 2-57[126 aa] C 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8cxq[3] D pan-sarbecovirus nanobody 1-22[122 aa] A 100.0
/99.8		 15
/15		 SPIKE_SARS2 Spike glycoprotein
8cy6[3] D pan-sarbecovirus nanobody 2-65[122 aa] A 100.0
/99.8		 13
/13		 SPIKE_SARS2 Spike glycoprotein
8cy9[3] D pan-sarbecovirus nanobody 1-23[121 aa] A 100.0
/99.8		 18
/18		 SPIKE_SARS2 Spike glycoprotein
8cya[3] F pan-sarbecovirus nanobody 2-67[127 aa] A 100.0
/99.8		 11
/11		 SPIKE_SARS2 Spike glycoprotein
8cyd[3] F pan-sarbecovirus nanobody 2-45[121 aa] A 100.0
/99.8		 15
/15		 SPIKE_SARS2 Spike glycoprotein
8csj[3] B 4-33 heavy chain[122 aa] A 100.0
/99.8		 10
/10		 SPIKE_SARS2 Spike glycoprotein
8csj[3] C 4-33 light chain[110 aa] A 100.0
/99.8		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7ls9[3] B 1-57 Fab heavy chain[129 aa] A 100.0
/99.8		 14
/14		 SPIKE_SARS2 Spike glycoprotein
8cyc[3] D pan-sarbecovirus nanobody 2-34[127 aa] A 100.0
/99.8		 16
/16		 SPIKE_SARS2 Spike glycoprotein
7l2f[3] D 5-24 heavy chain[126 aa] A 100.0
/99.8		 14
/14		 SPIKE_SARS2 Spike glycoprotein
7tb8[3] D The heavy chain of SARS-CoV-2 antibody A19-61.1[12.. A 100.0
/99.8		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7tb8[1] F The heavy chain of SARS-CoV-2 antibody A19-61.1[12.. C 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7tb8[3] E The light chain of SARS-COV-2 antibody A19-61.1[10.. A 100.0
/99.8		 9
/9		 SPIKE_SARS2 Spike glycoprotein
7lqv[3] D 4-8 Heavy Chain[125 aa] A 100.0
/99.8		 15
/15		 SPIKE_SARS2 Spike glycoprotein
7lqv[3] E 4-8 Light chain[105 aa] A 100.0
/99.8		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7ntc[1] D P008_056 Fab Heavy chain[224 aa] C 100.0
/99.8		 14
/14		 SPIKE_SARS2 Spike glycoprotein
7dzy[3] I Fab light chain of enhancing antibody 2490[213 aa].. A 100.0
/99.5		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7kqb[2] E Fab 5A6 light chain[214 aa] A 100.0
/99.8		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7kqb[1] G Fab 5A6 light chain[214 aa] A 100.0
/99.8		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7ntc[1] E P008_056 Fab Light chain[213 aa] C 100.0
/99.8		 12
/12		 SPIKE_SARS2 Spike glycoprotein
7qti[1] H P2G3 Light Chain[214 aa] I 100.0
/97.3		 1
/1		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
7u0p[1] F mAb 002_S21F2 light chain[215 aa] B 100.0
/99.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7uow[2] G Monoclonal antibody 034_32 light chain[215 aa] A 100.0
/99.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7upw[5] E SP1-77 Fab light chain[212 aa] A 100.0
/99.9		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8hlc[3] E light chain of 3711[214 aa] A 100.0
/99.8		 6
/6		 SPIKE_SARS2 Spike glycoprotein
8hlc[3] G light chain of 3711[214 aa] A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8hlc[3] D heavy chain of 3711[228 aa] A 100.0
/99.8		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7kqb[2] D Fab 5A6 heavy chain[220 aa] A 100.0
/99.8		 13
/13		 SPIKE_SARS2 Spike glycoprotein
7rw2[3] D 5-7 heavy chain[134 aa] A 100.0
/99.8		 22
/22		 SPIKE_SARS2 Spike glycoprotein
7rw2[3] E 5-7 light chain[106 aa] A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7v26[3] D XG005 Heavy chain[223 aa] A 100.0
/99.8		 10
/10		 SPIKE_SARS2 Spike glycoprotein
8k9b[4] B Heavy chain of S2H5 Fab[216 aa] A 100.0
/99.8		 14
/14		 SPIKE_SARS2 Spike glycoprotein
8k9b[4] C Light chain of S2H5 Fab[219 aa] A 100.0
/99.8		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7cwl[16] E Fab P17 heavy chain[120 aa] A 100.0
/100.0		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7cwl[16] G Fab P17 light chain[108 aa] A 100.0
/100.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7cwl[2] G Fab P17 light chain[108 aa] B 100.0
/100.0		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7cwn[8] N light chain of H014 Fab[107 aa] A 100.0
/100.0		 8
/8		 SPIKE_SARS2 Spike glycoprotein
7cws[3] G Light Chain of H014 Fab[107 aa] M 100.0
/100.0		 8
/8		 SPIKE_SARS2 Spike glycoprotein
7cwn[8] O heavy chain of H014 Fab[122 aa] A 100.0
/100.0		 16
/16		 SPIKE_SARS2 Spike glycoprotein
7cws[3] H Heavy Chain of H014 Fab[122 aa] M 100.0
/100.0		 8
/8		 SPIKE_SARS2 Spike glycoprotein
7e5s[1] J H014 heavy chain[120 aa] A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7cws[6] I Heavy Chain of FC05 Fab[120 aa] M 100.0
/100.0		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7cwu[9] C heavy chain of FC05 Fab[120 aa] G 100.0
/100.0		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7cws[6] J Light Chain of FC05 Fab[109 aa] M 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7cwu[3] D light chain of FC05 Fab[109 aa] G 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7e5r[6] S FC05 light chain[109 aa] G 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7cwt[3] D Light chain Fab of HB27[111 aa] A 100.0
/100.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7cwt[1] J Light chain Fab of HB27[111 aa] B 100.0
/100.0		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7e5s[1] L HB27 light chain[110 aa] A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7cwt[3] E Heavy chain Fab of HB27[118 aa] A 100.0
/100.0		 12
/12		 SPIKE_SARS2 Spike glycoprotein
7e5s[1] O HB27 heavy chain[119 aa] A 100.0
/99.8		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7vnc[6] B n3113[116 aa] A 100.0
/99.8		 16
/16		 SPIKE_SARS2 Spike glycoprotein
7vne[1] F n3113.1[116 aa] A 100.0
/99.8		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7kqe[3] A Fab 3D11 heavy chain[211 aa] C 100.0
/99.8		 9
/9		 SPIKE_SARS2 Spike glycoprotein
7vq0[3] D Neutralizing nanobody P86[116 aa] A 100.0
/99.7		 19
/19		 SPIKE_SARS2 Spike glycoprotein
7vq0[1] D Neutralizing nanobody P86[116 aa] B 100.0
/99.7		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7vq0[1] E Neutralizing nanobody P86[116 aa] C 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7kqe[12] B Fab 3D11 light chain[212 aa] C 100.0
/99.8		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7u0x[1] G mAb 002-13 Light chain[216 aa] A 100.0
/99.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7u0x[1] E mAb 002-13 Light chain[216 aa] B 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7u0x[1] E mAb 002-13 Light chain[216 aa] C 100.0
/99.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7wo4[2] N mAb15 VL[215 aa] B 100.0
/99.7		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7lrt[1] F antibody A23-58.1 light chain[213 aa] I 100.0
/99.4		 3
/3		 SPIKE_SARS2 SARS-CoV-2 spike glycoprotein
7u0q[2] D mAb 002-02 light chain[214 aa] A 100.0
/99.4		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7woa[5] E mAb60 VL[212 aa] A 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wo4[9] F mAb15 VH[225 aa] A 100.0
/99.7		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7woa[5] D mAb60 VH[204 aa] A 100.0
/99.7		 9
/9		 SPIKE_SARS2 Spike glycoprotein
7woa[1] D mAb60 VH[204 aa] B 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wob[1] D mAb60 VH[204 aa] B 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7v26[3] E XG005 Light Chain[203 aa] A 100.0
/99.8		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7v26[4] E XG005 Light Chain[203 aa] C 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7x08[3] D heavy chain of 2G1[214 aa] A 100.0
/99.5		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7x08[3] H heavy chain of 2G1[214 aa] A 100.0
/99.5		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7swx[1] D SARS2-57 Fv heavy chain[117 aa] A 100.0
/99.5		 9
/9		 SPIKE_SARS2 Spike glycoprotein
7swx[1] E SARS2-57 Fv light chain[112 aa] A 100.0
/99.5		 6
/6		 SPIKE_SARS2 Spike glycoprotein
8hld[3] D heavy chain of 26434[222 aa] A 100.0
/99.5		 9
/9		 SPIKE_SARS2 Spike glycoprotein
8hld[3] E light chain of 26434[209 aa] A 100.0
/99.5		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7dzx[1] D Fab Heavy chain of enhancing antibody[227 aa] C 100.0
/99.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7dzy[3] H Fab Heavy chain of enhancing antibody 2490[225 aa].. A 100.0
/99.5		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7lrt[1] E antibody A23-58.1 heavy chain[216 aa] I 100.0
/99.4		 10
/10		 SPIKE_SARS2 SARS-CoV-2 spike glycoprotein
7u0p[1] E mAb 002-S21F2 Heavy chain[224 aa] B 100.0
/99.4		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7u0q[4] E mAb 002-02 Heavy chain[222 aa] A 100.0
/99.4		 14
/14		 SPIKE_SARS2 Spike glycoprotein
8eyg[1] E Nanobody[118 aa] B 100.0
/99.4		 7
/7		 SPIKE_SARS2 Spike glycoprotein
8f4p[1] D Anti-S1 Nanobody[118 aa] B 100.0
/99.4		 10
/10		 SPIKE_SARS2 Spike glycoprotein
8gdr[1] C Monoclonal antibody 002-S21B10 light chain variabl.. D 100.0
/99.4		 6
/6		 SPIKE_SARS2 Spike glycoprotein
8gdr[1] G Monoclonal antibody 002-S21B10 light chain variabl.. D 100.0
/99.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
8gdr[1] F Monoclonal antibody 002-S21B10 heavy chain variabl.. D 100.0
/99.4		 9
/9		 SPIKE_SARS2 Spike glycoprotein
7u0x[2] F mAb 002-13 heavy chain[234 aa] A 100.0
/99.4		 16
/16		 SPIKE_SARS2 Spike glycoprotein
7rq6[3] B CV3-13 Fab heavy chain[124 aa] A 100.0
/99.4		 12
/12		 SPIKE_SARS2 Spike glycoprotein
7rq6[3] C CV3-13 Fab light chain[107 aa] A 100.0
/99.4		 12
/12		 SPIKE_SARS2 Spike glycoprotein
7rbv[2] A PVI.V6-14 Fab light chain, variable region[107 aa].. C 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7rbv[2] A PVI.V6-14 Fab light chain, variable region[107 aa].. F 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7rbv[2] B PVI.V6-14 Fab heavy chain, variable region[126 aa].. C 100.0
/99.4		 13
/13		 SPIKE_SARS2 Spike glycoprotein
7tyz[3] B DARPin FSR22[155 aa] A 100.0
/99.4		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7uap[3] D C1520 Fab Heavy Chain[126 aa] A 100.0
/99.4		 18
/18		 SPIKE_SARS2 Spike glycoprotein
7uap[3] E C1520 Fab Light Chain[112 aa] A 100.0
/99.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7uz6[3] D M8a-28 Fab heavy chain[119 aa] A 100.0
/99.4		 13
/13		 SPIKE_SARS2 Spike glycoprotein
7uz6[3] E M8a-28 Fab light chain[106 aa] A 100.0
/99.4		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7n0g[5] D Synthetic nanobody (sybody), Sb45[121 aa] A 100.0
/99.4		 28
/28		 SPIKE_SARS2 Spike glycoprotein
7n0g[2] F Synthetic nanobody (sybody), Sb45[121 aa] A 100.0
/99.4		 8
/8		 SPIKE_SARS2 Spike glycoprotein
7n0g[1] E Synthetic nanobody (sybody), Sb45[121 aa] C 100.0
/99.4		 7
/7		 SPIKE_SARS2 Spike glycoprotein
8g70[2] K Nanosota-3[115 aa] A 100.0
/99.4		 20
/20		 SPIKE_SARS2 Spike glycoprotein
8g70[1] K Nanosota-3[115 aa] B 100.0
/99.4		 5
/5		 SPIKE_SARS2 Spike glycoprotein
8g70[3] D Nanosota-5[114 aa] A 100.0
/99.4		 11
/11		 SPIKE_SARS2 Spike glycoprotein
8g70[3] G Nanosota-6[118 aa] A 100.0
/99.4		 5
/5		 SPIKE_SARS2 Spike glycoprotein
8g70[3] I Nanosota-6[118 aa] A 100.0
/99.4		 12
/12		 SPIKE_SARS2 Spike glycoprotein
8g70[1] J Nanosota-4[127 aa] A 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8g70[1] J Nanosota-4[127 aa] C 100.0
/99.4		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7zjl[3] F REGN10987 Fab homologue (Light chain)[218 aa] A 100.0
/99.4		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7zjl[2] G REGN10987 Fab homologue (Heavy chain)[223 aa] A 100.0
/99.4		 9
/9		 SPIKE_SARS2 Spike glycoprotein
7n9t[3] E Nanobody Nb17[119 aa] A 100.0
/99.3		 9
/9		 SPIKE_SARS2 Spike glycoprotein
7n9t[3] F Nanobody Nb17[119 aa] A 100.0
/99.3		 6
/6		 SPIKE_SARS2 Spike glycoprotein
8w4f[3] D Tribody[197 aa] A 100.0
/99.3		 34
/34		 SPIKE_SARS2 Spike glycoprotein
8w4f[3] E Tribody[197 aa] A 100.0
/99.3		 31
/31		 SPIKE_SARS2 Spike glycoprotein
8w4f[1] E Tribody[197 aa] B 100.0
/99.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7tpr[3] F Nanobody 7A3[125 aa] A 100.0
/99.2		 18
/18		 SPIKE_SARS2 Spike glycoprotein
7tpr[1] H Nanobody 7A3[125 aa] A 100.0
/99.2		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7tpr[1] F Nanobody 7A3[125 aa] B 75.0
/99.2		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7tpr[1] F Nanobody 7A3[125 aa] C 100.0
/99.2		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7tpr[2] D Nanobody 8A2[132 aa] B 100.0
/99.2		 23
/23		 SPIKE_SARS2 Spike glycoprotein
7a94[6] D ACE2_HUMAN Angiotensin-converting enzyme 2[588 aa] A 100.0
/99.8		 14
/14		 SPIKE_SARS2 Spike glycoprotein
7df4[5] A ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] C 100.0
/99.8		 21
/21		 SPIKE_SARS2 Spike glycoprotein
7wcz[6] B Heavy chain of S5D2 Fab[214 aa] A 100.0
/99.0		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7wcz[6] C Light chain of S5D2 Fab[217 aa] A 100.0
/99.0		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7wd9[5] H Heavy chain of S3H3 Fab[217 aa] A 100.0
/99.0		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7wd9[5] I Light chain of S3H3 Fab[215 aa] A 100.0
/99.0		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7l2f[3] E 5-24 light chain[109 aa] A 100.0
/99.8		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7lrt[4] D antibody A23-58.1 light chain[108 aa] G 100.0
/99.4		 3
/3		 SPIKE_SARS2 SARS-CoV-2 spike glycoprotein
7ls9[3] C 1-57 Fab light chain[108 aa] A 100.0
/99.8		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7tcc[3] G Light chain of antibody B1-182.1[108 aa] A 50.0
/97.3		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7lrt[7] C antibody A23-58.1 heavy chain[123 aa] G 100.0
/99.4		 8
/8		 SPIKE_SARS2 SARS-CoV-2 spike glycoprotein
7tca[2] F Heavy chain of antibody A19-46.1[231 aa] B 100.0
/97.3		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7tca[2] G Light chain of antibody A19-46.1[216 aa] B 81.8
/97.3		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7tcc[3] D Heavy chain of antibody A19-46.1[126 aa] A 100.0
/97.3		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7tcc[3] E Light chain of antibody A19-46.1[110 aa] A 84.6
/97.3		 13
/13		 SPIKE_SARS2 Spike glycoprotein
7qti[1] G P2G3 Heavy Chain[228 aa] I 91.7
/97.3		 12
/12		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
7x6a[1] D Heavy chain of Fab BD55-5840[119 aa] B 87.5
/97.2		 8
/8		 SPIKE_SARS2 Spike glycoprotein
7x6a[1] E Light chain of Fab BD55-5840[109 aa] B 83.3
/97.2		 6
/6		 SPIKE_SARS2 Spike glycoprotein
8xbf[1] D O5C2, heavy chain[114 aa] A 76.9
/96.4		 13
/13		 SPIKE_SARS2 Spike glycoprotein
8xbf[1] F O5C2, heavy chain[114 aa] B 100.0
/96.4		 5
/5		 SPIKE_SARS2 Spike glycoprotein
8xbf[1] E O5C2, light chain[109 aa] A 85.7
/96.4		 7
/7		 SPIKE_SARS2 Spike glycoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
COMPOUND
1273 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
7qur[3] BA GE9
2,3,5-tris(iodanyl)benzamide[12 atoms] 		A 100.0
/100.0		 5
/5		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7qur[3] CA SIA
N-acetyl-alpha-neuraminic acid[21 atoms] 		A 100.0
/100.0		 8
/8		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7wgv[2] EA BLR
3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrr.. 		A 100.0
/100.0		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7e7b[5] XA VCG
2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-.. 		A 100.0
/100.0		 11
/11		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
7e7b[3] YA VCG
2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-.. 		A 100.0
/100.0		 3
/3		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
6zp2[15] S BLA
BILIVERDINE IX ALPHA[43 atoms] 		A 100.0
/99.8		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7nt9[8] HA BLA
BILIVERDINE IX ALPHA[43 atoms] 		A 100.0
/99.8		 10
/10		 SPIKE_SARS2 Spike glycoprotein
8p9y[1] NA XIO
[(2~{S})-2-[[4-(2-azanylethanoylamino)-7-[[(2~{S}).. 		A 100.0
/99.7		 1
/1		 SPIKE_SARS2 SPIKE_SARS2 Spike protein S1,Spike glycoprotein
8p9y[1] NA XIO
[(2~{S})-2-[[4-(2-azanylethanoylamino)-7-[[(2~{S}).. 		C 100.0
/99.7		 3
/3		 SPIKE_SARS2 SPIKE_SARS2 Spike protein S1,Spike glycoprotein
7tgx[1] I MAN
alpha-D-mannopyranose[11 atoms] 		A 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8uum[2] H MAN
alpha-D-mannopyranose[11 atoms] 		A 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6xr8[1936] NA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/100.0		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6xr8[144] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xr8[538] RA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/100.0		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6xr8[54] TA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zge[15] AB NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zge[15] HA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 5
/5		 SPIKE_SARS2 Spike glycoprotein
6zge[23] IA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6zge[22] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6zge[82] NA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6zgi[7] LA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zp2[21] AA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zp2[27] EA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6zp2[30] OA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zp2[19] U NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6zp2[121] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zp2[3] Z NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7a94[3] K NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7bnm[35] BA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.7		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7bnn[39] O NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7cn4[147] P NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/97.3		 2
/2		 A0A6B9WHD3_CVHSA Spike glycoprotein
7cn4[4] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 0.0
/97.3		 1
/1		 A0A6B9WHD3_CVHSA Spike glycoprotein
7cn4[142] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/97.3		 3
/3		 A0A6B9WHD3_CVHSA Spike glycoprotein
7cwt[54] R NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/100.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7cwt[23] S NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/100.0		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7cwt[4] Z NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7df4[7] BA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7df4[36] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		D 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7l2d[19] ZA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		D 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7lqv[2] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7lqv[1] K NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7lqv[4] L NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7lqv[32] M NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7lqv[4] Q NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7lqv[4] R NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7lqv[1] S NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7lrt[27] LA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		G 100.0
/99.4		 1
/1		 SPIKE_SARS2 SARS-CoV-2 spike glycoprotein
7lrt[12] WA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		H 100.0
/99.4		 1
/1		 SPIKE_SARS2 SARS-CoV-2 spike glycoprotein
7mm0[7] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		D 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7n1q[40] NA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7n1q[7] KA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7qdg[7] AA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.6		 1
/1		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7qdg[7] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.6		 2
/2		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7qdg[4] KA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.6		 2
/2		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7qdh[4] S NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/99.7		 1
/1		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7qdh[1] U NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.7		 1
/1		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7rbv[8] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7rq6[14] IA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		G 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7sbl[2] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7tb4[10] BA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/97.4		 2
/2		 A0A8A4XEV3_SARS2 Surface glycoprotein
7tb4[4] HA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/97.4		 2
/2		 A0A8A4XEV3_SARS2 Surface glycoprotein
7tb4[5] LA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/97.4		 2
/2		 A0A8A4XEV3_SARS2 Surface glycoprotein
7tb4[6] SA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/97.4		 1
/1		 A0A8A4XEV3_SARS2 Surface glycoprotein
7tb4[7] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 50.0
/97.4		 2
/2		 A0A8A4XEV3_SARS2 Surface glycoprotein
7tb4[1] AA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/97.3		 1
/1		 A0A8A4XEV3_SARS2 Surface glycoprotein
7tca[1] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/97.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7tgy[5] Z NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7to4[4] PA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/97.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7vrv[6] T NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7vrv[2] Z NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7vrv[3] HA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7vrv[1] S NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7vrw[1] KA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7wgv[3] GA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/99.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybk[1] XA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7zrv[1] OA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/97.3		 1
/1		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
8csj[1] AA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		E 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8cxn[1] U NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8gjm[1] BB NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8hxj[1] KA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/98.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8p99[4] N NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.7		 1
/1		 SPIKE_SARS2 SPIKE_SARS2 Spike protein S1,Spike glycoprotein
8p99[2] Q NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.7		 2
/2		 SPIKE_SARS2 SPIKE_SARS2 Spike protein S1,Spike glycoprotein
8p99[4] T NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.7		 1
/1		 SPIKE_SARS2 SPIKE_SARS2 Spike protein S1,Spike glycoprotein
8p99[3] V NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.7		 1
/1		 SPIKE_SARS2 SPIKE_SARS2 Spike protein S1,Spike glycoprotein
8p99[2] Z NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/99.7		 1
/1		 SPIKE_SARS2 SPIKE_SARS2 Spike protein S1,Spike glycoprotein
8p99[2] DA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.7		 1
/1		 SPIKE_SARS2 SPIKE_SARS2 Spike protein S1,Spike glycoprotein
8xbf[1] U NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/96.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
OTHERPOLY
1273 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
6xr8[3] O alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. A 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7qur[6] G alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. A 100.0
/100.0		 2
/2		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7qur[6] K alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. A 100.0
/100.0		 3
/3		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
6xr8[12] D alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/100.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6xr8[38] G alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/100.0		 7
/7		 SPIKE_SARS2 Spike glycoprotein
6xr8[21] J alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/100.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6xr8[3] JA alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xr8[35] K alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xr8[3] L alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/100.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6xr8[35] M alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/100.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6xr8[81] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/100.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6xr8[28] V alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/100.0		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7krq[45] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7krq[5] S alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7n1q[29] K alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7n1t[17] J alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.3		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7sbk[6] H alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7sbk[7] M alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7sbk[5] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7sbk[8] X alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7sbp[13] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.5		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7sbp[9] O alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.5		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7sbp[8] Z alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7sbt[3] K alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 85.7
/99.0		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7tnw[7] G alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/97.3		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7ybk[1] T alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. B 100.0
/99.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7ybk[1] U alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. B 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8d55[6] AA alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/97.6		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xr8[83] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/100.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7bnn[1] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. B 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. C 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7upw[6] T 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/99.9		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7ybk[1] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. B 100.0
/99.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
8cya[2] X 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7mxp[3] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. A 100.0
/99.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] HC beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] TA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7l2d[6] K beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7l2d[5] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.8		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7lrt[2] Z beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. I 100.0
/99.4		 2
/2		 SPIKE_SARS2 SARS-CoV-2 spike glycoprotein
7ls9[4] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7mxp[3] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.9		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7qo7[1] F beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/97.4		 3
/3		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7qo7[1] G beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/97.4		 1
/1		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7qo7[10] I beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/97.4		 1
/1		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7qo7[7] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/97.4		 4
/4		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7qo7[4] L beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/97.4		 2
/2		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7qo7[1] P beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 0.0
/97.4		 1
/1		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7rbv[6] O beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7tyz[3] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7u0q[3] V beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] F beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.0		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7ybh[3] H beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7ybh[2] K beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.0		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7ybh[2] V beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] CA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.0		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] P beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7zrv[1] G beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 75.0
/97.3		 4
/4		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
7zrv[1] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/97.3		 2
/2		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
8cya[5] G beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8cya[4] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.8		 4
/4		 SPIKE_SARS2 Spike glycoprotein
8cya[1] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8cya[1] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7lrt[3] S alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. G 100.0
/99.4		 1
/1		 SPIKE_SARS2 SARS-CoV-2 spike glycoprotein
8cyb[1] F alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8cyb[2] G alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cyb[2] H alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cyb[2] J alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.8		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7qo7[1] D alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/97.4		 5
/5		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7tyz[3] G alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/99.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] J alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/99.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cyb[1] W alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. C 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cyb[1] I alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cyb[1] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cyb[1] X alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. C 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8csj[1] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(2-3)-2-a.. D 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8csj[1] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(2-3)-2-a.. E 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7tb8[1] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-a.. A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7vnc[5] E 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7vnc[1] O 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8hlc[3] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7qdg[1] N 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.6		 1
/1		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7rbv[3] EA alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. C 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7rbv[3] K alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. C 100.0
/99.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7rbv[3] L alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. C 100.0
/99.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7rbv[3] I alpha-D-mannopyranose-(1-4)-[alpha-D-mannopyranose.. C 100.0
/99.4		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7rbv[3] J alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. C 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6xr8[236] E 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/100.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6xr8[47] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/100.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6xr8[110] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xr8[37] U 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/100.0		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6zge[23] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6zge[26] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6zge[15] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6zge[20] J 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6zge[63] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6zge[734] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6zge[15] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zge[6] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6zge[8] R 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 6
/6		 SPIKE_SARS2 Spike glycoprotein
6zp2[3] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zp2[21] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6zp2[23] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7cn4[99] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/97.3		 2
/2		 A0A6B9WHD3_CVHSA Spike glycoprotein
7cn4[98] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 80.0
/97.3		 5
/5		 A0A6B9WHD3_CVHSA Spike glycoprotein
7cwm[99] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/100.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7cws[10] P 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. M 100.0
/100.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7df4[5] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. D 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7dwy[22] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.8		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7e7b[67] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/100.0		 4
/4		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
7e7b[47] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/100.0		 3
/3		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
7krr[6] R 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7lrt[11] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. G 100.0
/99.4		 3
/3		 SPIKE_SARS2 SARS-CoV-2 spike glycoprotein
7mm0[3] J 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. D 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7n1q[19] E 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.3		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7n1q[29] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.3		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7n1q[19] Z 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.3		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7n1v[2] AA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7n1v[4] Z 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7rbv[19] P 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7rbv[5] Z 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7sbs[3] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 66.7
/99.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7swx[4] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.5		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7swx[1] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7swx[2] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7swx[5] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.5		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7tb4[4] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/97.3		 4
/4		 A0A8A4XEV3_SARS2 Surface glycoprotein
7tgw[8] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/97.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7vnc[4] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7vq0[1] AA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7vrv[3] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7vrv[1] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybh[2] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7ybh[3] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybh[2] R 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.0		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7ybh[2] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8gdr[1] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. D 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8gdr[1] J 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. D 100.0
/99.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
8hxj[3] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/98.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8p99[2] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.7		 2
/2		 SPIKE_SARS2 SPIKE_SARS2 Spike protein S1,Spike glycoprotein
7tgx[1] D alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.7		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7tgx[1] E alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7tgx[1] F alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. B 100.0
/99.7		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7tgx[1] G alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. B 100.0
/99.7		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8uum[1] D alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8uum[2] E alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/99.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8uum[1] F alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. B 100.0
/99.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8uum[1] G alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. B 100.0
/99.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
HOMO
1273 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
6zgh[1] A SPIKE_SARS2 Spike glycoprotein[875 aa] B 100.0
/99.8		 72
/72		 SPIKE_SARS2 Spike glycoprotein
6zgh[1] A SPIKE_SARS2 Spike glycoprotein[875 aa] C 100.0
/99.8		 82
/82		 SPIKE_SARS2 Spike glycoprotein
6xr8[435] B SPIKE_SARS2 Spike glycoprotein[1107 aa] A 100.0
/100.0		 134
/134		 SPIKE_SARS2 Spike glycoprotein
6xr8[324] C SPIKE_SARS2 Spike glycoprotein[1107 aa] A 100.0
/100.0		 123
/123		 SPIKE_SARS2 Spike glycoprotein
6zge[38] B SPIKE_SARS2 Spike glycoprotein[1098 aa] A 99.1
/99.8		 108
/108		 SPIKE_SARS2 Spike glycoprotein
6zge[38] C SPIKE_SARS2 Spike glycoprotein[1098 aa] A 100.0
/99.8		 94
/94		 SPIKE_SARS2 Spike glycoprotein
6zp2[111] B SPIKE_SARS2 Spike glycoprotein[1097 aa] A 100.0
/99.8		 110
/110		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] F SPIKE_SARS2 Spike glycoprotein[1108 aa] A 100.0
/99.8		 9
/9		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] D SPIKE_SARS2 Spike glycoprotein[1120 aa] C 100.0
/99.8		 12
/12		 SPIKE_SARS2 Spike glycoprotein
7lqv[4] B SPIKE_SARS2 Spike glycoprotein[1112 aa] A 100.0
/99.8		 86
/86		 SPIKE_SARS2 Spike glycoprotein
7lqv[4] C SPIKE_SARS2 Spike glycoprotein[1087 aa] A 100.0
/99.8		 82
/82		 SPIKE_SARS2 Spike glycoprotein
7n9t[3] B SPIKE_SARS2 Spike glycoprotein[1123 aa] A 100.0
/99.3		 69
/69		 SPIKE_SARS2 Spike glycoprotein
7n9t[15] C SPIKE_SARS2 Spike glycoprotein[1123 aa] A 100.0
/99.3		 74
/74		 SPIKE_SARS2 Spike glycoprotein
7vhk[12] B SPIKE_SARS2 Spike glycoprotein[1077 aa] A 100.0
/99.8		 96
/96		 SPIKE_SARS2 Spike glycoprotein
7wo4[1] K SPIKE_SARS2 Spike glycoprotein[1076 aa] B 100.0
/99.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wo4[1] B SPIKE_SARS2 Spike glycoprotein[1076 aa] K 100.0
/99.7		 2
/2		 SPIKE_SARS2 Spike glycoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
PRECIPITANT
1273 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
7e7b[6] VA ELA
9-OCTADECENOIC ACID[20 atoms] 		A 100.0
/100.0		 14
/14		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
7e7b[6] WA ELA
9-OCTADECENOIC ACID[20 atoms] 		A 100.0
/100.0		 4
/4		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
6zp2[18] DA EIC
LINOLEIC ACID[20 atoms] 		A 100.0
/99.8		 13
/13		 SPIKE_SARS2 Spike glycoprotein
6zp2[34] HA EIC
LINOLEIC ACID[20 atoms] 		A 100.0
/99.8		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7dwy[16] HA EIC
LINOLEIC ACID[20 atoms] 		A 100.0
/99.8		 13
/13		 SPIKE_SARS2 Spike glycoprotein
7wgv[3] AA EIC
LINOLEIC ACID[20 atoms] 		A 100.0
/100.0		 15
/15		 SPIKE_SARS2 Spike glycoprotein
7wgv[3] AB EIC
LINOLEIC ACID[20 atoms] 		A 100.0
/100.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7z3z[2] EA STE
STEARIC ACID[20 atoms] 		A 100.0
/99.5		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7z3z[2] RA STE
STEARIC ACID[20 atoms] 		A 100.0
/99.5		 2
/2		 SPIKE_SARS2 Spike glycoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.